Biotech & MedTech
-
Thomas Smeenk on Hemostemix’s autologous stem cell therapy technology and why some call it ‘the fountain of youth’
In a recent InvestorIntel interview, Tracy Weslosky spoke with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc.…
-
Mental health at the forefront of new research into Psychedelics
The liberalization of cannabis usage (pun intended) has made strides in opening up other aspects of the drug…
-
Will Sixth Wave help prevent a fourth wave?
Sixth Wave Innovations Inc. (CSE: SIXW | OTCQB: ATURF) is a nanotechnology company focused on extraction and detection…
-
Predictiv AI – Using Artificial Intelligence to Solve “Real World” Problems
Predictiv AI’s ThermalPass Part of a Back-to-Work Strategy The U.S. Centers for Disease Control and Prevention (CDC) reported…
-
StageZero Life Sciences James Howard-Tripp on the recent LOI to Acquire Health Clinics Limited
In a recent InvestorIntel interview, Tracy Weslosky spoke with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
Diagnos’ André Larente on Entering the DACH and Central European Healthcare Market
In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente President of Diagnos Inc. (TSXV: ADK |…
-
David Kerbel on launching Rritual’s premium brand of functional superfoods in Rite Aid stores throughout the USA
In a recent InvestorIntel interview, Tracy Weslosky spoke with David Kerbel, CEO and Director of Rritual Superfoods Inc.…
-
Does Sernova have a cure for Type 1 Diabetes?
There are many impressive companies around the world trying to solve the world’s problems and make this a…
-
Welcome to the Big Leagues.
Valeo Pharma Inc. (CSE: VPH | OTCQB: VPHIF) has taken a big step forward in its business development…
-
Driving to deliver on their 800M mask coatings per month demand, ZEN Graphene up 746% over the past year
ZEN Graphene Solutions Ltd. (TSXV: ZEN) (‘ZEN’) continues to move at a rapid pace with demand for their…
